TEVA 7391 (Risedronate Sodium 30 mg)
Pill with imprint TEVA 7391 is White, Round and has been identified as Risedronate Sodium 30 mg. It is supplied by Teva Pharmaceuticals USA Inc..
Risedronate is used in the treatment of paget's disease; prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 30 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 7391
Risedronate Sodium
- Imprint
- TEVA 7391
- Strength
- 30 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC)
- 00093-3100
More about risedronate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 53 Reviews
- Drug class: bisphosphonates
- FDA Alerts (3)
Consumer resources
- Patient Information
- Risedronate (Advanced Reading)
- Risedronate Delayed-Release Tablets
- Risedronate Tablets
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.